Try
Drägerwerk AG & Co. KGaA
DRW3Germany
40 filed reports · 255 financial concepts · 5 earnings calls · 0 media appearances
Filed reports
40 reports · Mar 2015 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Q1Bundesanzeiger | 12 | 1,282 | Mar 2015 to Mar 2026 |
| Half YearBundesanzeiger | 11 | 1,337 | Jun 2015 to Jun 2026 |
| Q3Bundesanzeiger | 11 | 1,348 | Sep 2015 to Sep 2025 |
| AnnualBundesanzeiger | 6 | 557 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | half year | Jun 30, 2026 | Jun 30, 2026 | 216 | Open |
| FY2026 Q1 | q1 | Mar 31, 2026 | Mar 31, 2026 | 144 | Open |
| FY2025 | annual | Dec 31, 2025 | Dec 31, 2025 | 121 | Open |
| FY2025 Q3 | q3 | Sep 30, 2025 | Sep 30, 2025 | 129 | Open |
| FY2025 Q2 | half year | Jun 30, 2025 | Jun 30, 2025 | 135 | Open |
| FY2025 Q1 | q1 | Mar 31, 2025 | Mar 31, 2025 | 104 | Open |
| FY2024 | annual | Dec 31, 2024 | Dec 31, 2024 | 121 | Open |
| FY2024 Q3 | q3 | Sep 30, 2024 | Sep 30, 2024 | 125 | Open |
| FY2024 Q2 | half year | Jun 30, 2024 | Jun 30, 2024 | 124 | Open |
| FY2024 Q1 | q1 | Mar 31, 2024 | Mar 31, 2024 | 102 | Open |
| FY2023 | annual | Dec 31, 2023 | Dec 31, 2023 | 104 | Open |
| FY2023 Q3 | q3 | Sep 30, 2023 | Sep 30, 2023 | 124 | Open |
Financial data
255 concepts · 4,524 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS227 concepts · 4,227 facts · Dec 2014 to Jun 2026
- Gross Profit69 · Mar 2015 to Jun 2026
- Income Tax Expense (Benefit)64 · Mar 2015 to Jun 2026
- Revenue62 · Jan 2015 to Jun 2026
- EBIT 159 · Mar 2015 to Jun 2026
- Cost of Revenue57 · Mar 2015 to Jun 2026
- Earnings before income taxes57 · Mar 2015 to Jun 2026
- Earnings to non-controlling interests57 · Mar 2015 to Jun 2026
- Financial result (before interest result)57 · Mar 2015 to Jun 2026
- General administrative costs57 · Mar 2015 to Jun 2026
- Marketing and selling expenses57 · Mar 2015 to Jun 2026
- Other financial result57 · Mar 2015 to Jun 2026
- Other operating income57 · Mar 2015 to Jun 2026
- Other operating expenses56 · Mar 2015 to Jun 2026
- Earnings after income taxes54 · Mar 2015 to Jun 2026
- per preferred share (in €)54 · Jun 2015 to Jun 2026
- per common share (in €)50 · Jun 2015 to Jun 2026
- Research and development costs47 · Mar 2015 to Dec 2024
- Result from other investments43 · Mar 2015 to Jun 2026
- Capital stock38 · Dec 2014 to Jun 2026
- Capital reserves37 · Mar 2015 to Jun 2026
- + Cash inflow from disposals of property, plant and equipment37 · Mar 2015 to Jun 2026
- Change in cash and cash equivalents in the reporting period37 · Mar 2015 to Jun 2026
- Currency translation adjustment for foreign subsidiaries37 · Mar 2015 to Jun 2026
- Deferred taxes on remeasurements of defined benefit pension plans37 · Mar 2015 to Jun 2026
Segment21 concepts · 262 facts · Mar 2016 to Jun 2026
- Medical division42 · Mar 2016 to Jun 2026
- Revenue32 · Mar 2016 to Jun 2026
- thereof Germany26 · Sep 2017 to Jun 2026
- EBIT 324 · Mar 2016 to Jun 2026
- Capital employed 4, 523 · Sep 2017 to Jun 2026
- EBITDA 221 · Sep 2017 to Jun 2026
- DVA 6, 717 · Sep 2017 to Jun 2026
- EBIT 2/Net sales %12 · Sep 2017 to Sep 2020
- DVA 5, 6 € million9 · Mar 2016 to Sep 2020
- thereof APAC8 · Mar 2026 to Jun 2026
- thereof EMEA8 · Mar 2026 to Jun 2026
- Depreciation & Amortization7 · Sep 2017 to Sep 2020
- EBIT 3 / net sales 17 · Mar 2016 to Jun 2026
- Gross Profit7 · Mar 2026 to Jun 2026
- Cost of Revenue6 · Mar 2026 to Jun 2026
- Functional expenses4 · Mar 2026 to Jun 2026
- EBITDA 1 € million3 · Mar 2016 to Sep 2017
- Financial Result (before Interest result)2 · Mar 2026
- thereof Americas2 · Jun 2026
- Capital employed 2,3 € million1 · Mar 2016
- Depreciation € million1 · Mar 2016
KPI5 concepts · 33 facts · Sep 2015 to Jun 2026
- EBIT margin12 · Sep 2015 to Jun 2026
- Gross Profit12 · Mar 2017 to Jun 2026
- Equity ratio 4 %5 · Sep 2016 to Jun 2020
- R&D ratio3 · Jun 2023 to Jun 2025
- Free cash flow1 · Dec 2024
APM2 concepts · 2 facts · Jun 2026
- DVA1 · Jun 2026
- free cash flow1 · Jun 2026
Segments
262 factsFigures broken down by business line, region, product or another axis the company reports on.
Division6 members · 148 facts
- Medical division65 · Mar 2016 to Jun 2026
- Safety division65 · Mar 2016 to Jun 2026
- Dräger Medical division7 · Mar 2020
- Dräger Safety division7 · Mar 2020
- Medical division 12 · Mar 2016
- Safety division 12 · Mar 2016
Region6 members · 114 facts
- Europe57 · Mar 2016 to Sep 2020
- Americas39 · Sep 2017 to Jun 2026
- Africa, Asia, Australia15 · Sep 2017 to Sep 2018
- Africa, Asia, Australia 11 · Mar 2016
- Americas 11 · Mar 2016
- Europe 11 · Mar 2016
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
5 calls · Mar 2025 to Mar 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2025 Q4Mar 24, 2026
- FY2025 Q3Oct 29, 2025
- FY2025 Q2Jul 29, 2025
- FY2025 Q1May 2, 2025
- FY2024 Q1Mar 31, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.